The Role of Trust in Delayed HIV Diagnosis in a Diverse, Urban Population

Legacy Community Health Services, Houston, TX, USA.
AIDS and Behavior (Impact Factor: 3.49). 12/2011; 17(1). DOI: 10.1007/s10461-011-0114-9
Source: PubMed


Delayed diagnosis of HIV infection is a common problem. We hypothesized that persons with less trust in physicians and in the healthcare system would be diagnosed with lower CD4 cell counts than persons with more trust because they would delay seeking healthcare. From January 2006 to October 2007, 171 newly diagnosed HIV-infected persons, not yet in HIV primary care, were recruited from HIV testing sites in Houston, Texas, that primarily serve the under- and un-insured. The participants completed instruments measuring trust in physicians and trust in the healthcare system. Initial CD4 cell counts were obtained from medical record review. Mean trust scores for participants with CD4 cell counts ≥200 cells/mm(3) were compared with scores from participants with CD4 cell counts <200 cells/mm(3). We found that 51% of the cohort was diagnosed with a CD4 cell count <200 cells/mm(3). Neither trust in physicians nor trust in the healthcare system was an independent predictor of delayed diagnosis of HIV infection. In multivariate analysis, men who have sex with men and injection drug users were more likely to have early HIV diagnosis. Race/ethnicity was the only variable statistically significantly predictive of trust in physicians and in the healthcare system. Hispanics had the highest trust scores, followed by Blacks and Whites. Low trust is likely not a barrier to timely diagnosis of HIV infection.

Download full-text


Available from: Richard Michael Grimes, Apr 22, 2014
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Resiliency factors such as social support have been associated with more frequent HIV testing among MSM. We examined the association between social support and delayed HIV testing in the context of structural discrimination and individual factors among young Black MSM. We combined two independent cross-sectional samples recruited 1 year apart from a venue-based, modified time-location sampling study of young Black MSM aged 18-29 years in the US South. Our subsample (N = 813) was men who self-reported not being HIV positive and who indicated they had one or more male sex partners in the past 2 months. Using a social epidemiology framework we estimated associations of structural (racism and homophobia), social (social support from other Black MSM friends) and individual factors with delayed HIV testing (>6 months ago) using logistic regression. Bivariate analyses demonstrated that individual level variables as well as experiences of racism (OR 1.20, 95% CI 1.02-1.41) and homophobia (OR 1.49, 95 % CI 1.02-2.17) were associated with higher risk of delayed HIV testing. Receiving social support from other Black MSM friends was associated with lower risk of delayed HIV testing (OR 0.80, 95 % CI 0.67-0.95). In multivariable models, social support remained significantly associated with lower risk of delayed HIV testing after inclusion of structural and individual level variables. Social support has a positive and robust association with HIV testing among young Black MSM. Whether community building and development of resiliency factors can overcome structural, social, and individual-level barriers to HIV prevention and care for young Black MSM warrants further study.
    AIDS and Behavior 09/2013; 18(5). DOI:10.1007/s10461-013-0608-8 · 3.49 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Social support predicts adherence to antiretroviral therapy (ART) in some settings but has not been well studied in persons newly diagnosed with HIV infection as a predictor of success through the cascade of HIV care. One hundred sixty-eight persons newly diagnosed with HIV completed the Medical Outcomes Study Social Support Survey at diagnosis, and 129 were successfully followed for more than 12 months. Outcomes were earlier diagnosis of HIV infection, linkage to care, retention in care, ART use by 1 year, and adherence to ART. Higher social support scores (either overall or on a subscale) were associated with earlier HIV diagnosis, timely linkage to care, and adherence to ART. Social support did not predict use of ART or retention in HIV care. Success navigating some of the steps of HIV care is more likely with social support, but it is not sufficient to ensure success across the continuum of care.
    The Journal of the Association of Nurses in AIDS Care: JANAC 02/2014; 25(5). DOI:10.1016/j.jana.2013.12.002 · 1.27 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The National HIV/AIDS Strategy emphasizes virologic suppression to reduce HIV incidence in the United States. We assessed temporal trends of and disparities in time to combination antiretroviral therapy (cART) initiation and HIV virologic suppression (VS) in a large, demographically diverse cohort of HIV-infected patients. We included antiretroviral-naïve HIV Outpatient Study (HOPS) participants from 2000-2013 enrolled within six months of their HIV diagnosis who attended ≥ 2 HIV care-related visits. We evaluated time from HIV diagnosis to first use of cART, time from HIV diagnosis to VS and time from first use of cART to VS. Kaplan-Meier time-to-event curves and Cox proportional hazards models were used to assess temporal trends and correlates of initiating cART and achieving HIV VS (<500 copies/mL). Among 1,156 HOPS patients (median age, 37 years; 43.2% non-Hispanic/Latino black [NHB], 14.1% Hispanic/Latino), estimated median times from HIV diagnosis to cART initiation, and from HIV diagnosis to VS, both shortened by > 40% during the 13.5-year study period, reaching, respectively, 2.5 and 5.4 months. In multivariable analyses, NHB patients (as compared with non-Hispanic/Latino white) and those who had injected drugs (as compared with those who did not) initiated cART in a less timely fashion. After adjusting for CD4+ cell count and viral load at cART initiation, NHB patients and those aged < 30 years (compared with ≥ 40 years) had lower rates of VS. Despite improvements in HIV treatment over time, patients who were NHB, younger, or used injection drugs had less favorable outcomes.
    JAIDS Journal of Acquired Immune Deficiency Syndromes 04/2015; Publish Ahead of Print(1). DOI:10.1097/QAI.0000000000000652 · 4.56 Impact Factor